Related Experiment Video
Updated: Jul 2, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Prevention of cancer by inhibiting aging
1Cancer Center, Ordway Research Institute, and Oncotarget, Albany, NY 12208, USA. Blagosklonny@oncotarget.com
Abstract:
Aging is associated with cancer, in particular with breast, prostate, colon, lung, stomach, bladder and skin cancer. This article discusses how aging predisposes one to cancer. In principle, inhibition of aging should delay cancer. But is it possible to slow aging? As recently proposed, the nutrient-sensing TOR (target of rapamycin) pathway is involved in cellular and organismal aging. In rodents, certain conditions that interfere with the TOR pathway slow aging and prevent cancer. Retrospective analysis of clinical data reveals that inhibitors of TOR prevent cancer in humans. This article envisions a potential clinical use of TOR inhibitors in order to slow aging and delay cancer.
Insights
Slowing aging may prevent cancer. Targeting the nutrient-sensing TOR pathway, involved in aging, with inhibitors shows promise in delaying cancer in both rodents and humans.
Area of Science:
- Gerontology
- Oncology
- Molecular Biology
Background:
- Aging is a significant risk factor for various cancers, including breast, prostate, colon, lung, stomach, bladder, and skin cancer.
- The nutrient-sensing target of rapamycin (TOR) pathway is increasingly recognized for its role in regulating cellular and organismal aging.
Purpose of the Study:
- To explore the link between aging and cancer predisposition.
- To investigate the potential of targeting the TOR pathway to slow aging and prevent cancer.
- To review evidence for TOR inhibitors in cancer prevention.
Main Methods:
- Review of scientific literature on aging and cancer.
- Analysis of studies investigating TOR pathway modulation in aging models (rodents).
- Retrospective analysis of clinical data on TOR inhibitor use and cancer incidence in humans.
Main Results:
- Conditions interfering with the TOR pathway have been shown to slow aging and prevent cancer in rodents.
- Retrospective clinical data suggest that TOR inhibitors are associated with cancer prevention in humans.
Conclusions:
- Inhibition of the TOR pathway presents a potential strategy for slowing aging and delaying cancer onset.
- TOR inhibitors may have a future clinical application in cancer prevention by targeting the aging process.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...